Decision Aid for Gastroesophageal Reflux Disease Management
This study is not yet open for participant recruitment.
Verified April 2013 by Massachusetts General Hospital
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
Chin Hur, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01641887
First received: July 11, 2012
Last updated: April 1, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is to test a decision aid that is designed to help patients make decision regarding management of their gastroesophageal reflux disease (GERD). Once the decision aid is constructed we will test and assess the aid on ~100 patients who have GERD to assess effectiveness.
| Condition | Intervention |
|---|---|
|
Gastroesophageal Reflux Disease Esophageal Cancer Barrett's Esophagus |
Other: Decision Aid |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Personalized Decision Aid for the Management of Gastroesophageal Reflux Disease |
Resource links provided by NLM:
Further study details as provided by Massachusetts General Hospital:
Primary Outcome Measures:
- Participant acceptability [ Time Frame: Patients will be surveyed on the day of the decision aid (1 day). ] [ Designated as safety issue: No ]Patients will be surveyed after using the intervention to determine if they felt it was useful and whether they would recommend it to others.
- Participant Satisfaction [ Time Frame: Patients will be surveyed on the day of the decision aid (1 day). ] [ Designated as safety issue: No ]The Patient Satisfaction with Decision Scale will be adapted for this study. This is a six-item scale has been shown to be reliable and valid.
Secondary Outcome Measures:
- Patient decisions [ Time Frame: Patients will be surveyed on the day of the decision aid (1 day). ] [ Designated as safety issue: No ]Patient intervention choice will be solicited both before and after the decision aid.
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2014 |
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
GERD patients
Patients who have GERD will be recruited for this study.
|
Other: Decision Aid
Patients will use a decision aid administered on a computer.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients who have GERD who have not yet had endoscopy.
Criteria
Inclusion Criteria:
- Patients with GERD,
- Age at least 18,
- Able to give consent
Exclusion Criteria:
- Unable to perform decision aid on a computer
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01641887
Contacts
| Contact: Chin Hur, MD, MPH | 617.724.4445 | chur@partners.org |
Locations
| United States, Massachusetts | |
| Massachusetts General Hospital | Not yet recruiting |
| Boston, Massachusetts, United States, 02114 | |
| Contact: Chin Hur 617-724-4445 chur@partners.org | |
| Principal Investigator: Chin Hur, MD, MPH | |
Sponsors and Collaborators
Massachusetts General Hospital
More Information
No publications provided
| Responsible Party: | Chin Hur, Principal Investigator, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT01641887 History of Changes |
| Other Study ID Numbers: | 2012-MGH-Hur-GERD |
| Study First Received: | July 11, 2012 |
| Last Updated: | April 1, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Massachusetts General Hospital:
|
GERD Heartburn Decision Aid |
Additional relevant MeSH terms:
|
Barrett Esophagus Esophageal Diseases Esophageal Neoplasms Gastroesophageal Reflux Digestive System Abnormalities Digestive System Diseases Gastrointestinal Diseases |
Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms Head and Neck Neoplasms Esophageal Motility Disorders Deglutition Disorders |
ClinicalTrials.gov processed this record on May 23, 2013